Century Therapeutics Stock Price Patterns

IPSC Stock  USD 1.90  0.11  5.47%   
The RSI of Century Therapeutics' share price is above 70 at the present time. This usually indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Century, making its price go up or down.

Momentum 77

 Buy Stretched

 
Oversold
 
Overbought
The successful prediction of Century Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Century Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Century Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.33)
EPS Estimate Current Year
(0.13)
EPS Estimate Next Year
(0.97)
Wall Street Target Price
3.5
EPS Estimate Current Quarter
(0.39)
Using Century Therapeutics hype-based prediction, you can estimate the value of Century Therapeutics from the perspective of Century Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Century Therapeutics using Century Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Century using crowd psychology based on the activity and movement of Century Therapeutics' stock price.

Century Therapeutics Implied Volatility

    
  0.16  
Century Therapeutics' implied volatility exposes the market's sentiment of Century Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Century Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Century Therapeutics stock will not fluctuate a lot when Century Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Century Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Century because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Century Therapeutics after-hype prediction price

    
  USD 1.9  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Century Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Century Stock refer to our How to Trade Century Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Century Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.091.7311.63
Details
Naive
Forecast
LowNextHigh
0.031.6111.52
Details
6 Analysts
Consensus
LowTargetHigh
3.193.503.89
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.39-0.24-0.1
Details

Century Therapeutics After-Hype Price Density Analysis

As far as predicting the price of Century Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Century Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Century Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Century Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Century Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Century Therapeutics' historical news coverage. Century Therapeutics' after-hype downside and upside margins for the prediction period are 0.10 and 11.80, respectively. We have considered Century Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.90
1.90
After-hype Price
11.80
Upside
Century Therapeutics is abnormally volatile at this time. Analysis and calculation of next after-hype price of Century Therapeutics is based on 3 months time horizon.

Century Therapeutics Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Century Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Century Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Century Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  2.30 
9.83
  0.32 
  0.01 
9 Events / Month
4 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.90
1.90
0.00 
7,021  
Notes

Century Therapeutics Hype Timeline

Century Therapeutics is currently traded for 1.90. The entity has historical hype elasticity of 0.32, and average elasticity to hype of competition of 0.01. Century is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 2.3%. %. The volatility of related hype on Century Therapeutics is about 245750.0%, with the expected price after the next announcement by competition of 1.91. About 25.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.94. Some equities with similar Price to Book (P/B) outperform the market in the long run. Century Therapeutics has Price/Earnings To Growth (PEG) ratio of 0.26. The entity recorded a loss per share of 0.32. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 9 days.
Check out Century Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Century Stock refer to our How to Trade Century Stock guide.

Century Therapeutics Related Hype Analysis

Having access to credible news sources related to Century Therapeutics' direct competition is more important than ever and may enhance your ability to predict Century Therapeutics' future price movements. Getting to know how Century Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Century Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
COEPCoeptis Therapeutics 0.64 6 per month 0.00 (0.02) 7.44 (6.12) 22.14 
MDCXMedicus Pharma Ltd 0.01 11 per month 0.00 (0.21) 6.77 (8.93) 21.20 
CUECue Biopharma 0.01 8 per month 0.00 (0.12) 11.11 (12.50) 50.98 
EQEquillium(0.01)10 per month 6.47  0.03  19.26 (12.50) 43.07 
SNTISenti Biosciences(0.09)8 per month 0.00 (0.14) 7.73 (9.50) 53.50 
TELOTelomir Pharmaceuticals Common 0.04 5 per month 0.00 (0.14) 4.00 (6.00) 15.74 
OSTXOS Therapies Incorporated(0.14)8 per month 0.00 (0.11) 5.49 (6.84) 16.39 
KPTIKaryopharm Therapeutics(0.25)9 per month 4.10  0.02  8.02 (6.78) 18.05 
OTLKOUTLOOK THERAPEUTICS INC(0.04)11 per month 0.00 (0.11) 11.32 (11.11) 73.07 
GNTAGenenta Science SpA(0.13)6 per month 0.00 (0.22) 6.96 (13.33) 39.96 

Century Therapeutics Additional Predictive Modules

Most predictive techniques to examine Century price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Century using various technical indicators. When you analyze Century charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Century Therapeutics Predictive Indicators

The successful prediction of Century Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Century Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Century Therapeutics based on analysis of Century Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Century Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Century Therapeutics's related companies.
 2023 2024 2025 2026 (projected)
Interest Debt Per Share0.820.680.620.52
Revenue Per Share0.03770.08380.09630.0775

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for Century Stock analysis

When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
CEOs Directory
Screen CEOs from public companies around the world